Get started
Author

Tania Szado

Observed names: Szado, T., Szado, Tania, T Szado, T. Szado
Institution: Genentech
Observed institutions: Medigene (Germany), BC Cancer Agency, Roche (United States), Providence Health Care, Babraham Institute, Sunnybrook Health Science Centre, University of British Columbia, Genentech, St. Paul's Hospital, Samsung Medical Center, Taipei Veterans General Hospital, Centre Hospitalier Universitaire de Besançon, Leningrad Regional Cancer Center, Hospital Clínico Universitario de Valencia, Centre Georges François Leclerc, Roche (United Kingdom), Institute of Oncology NN Petrov, Children's & Women's Health Centre of British Columbia, Vall d'Hebron Hospital Universitari, Hospital Del Mar, Centre Oscar Lambret, Koo Foundation Sun Yat-Sen Cancer Center, Fondazione IRCCS Istituto Nazionale dei Tumori, Instacart (United States), Centre for Heart Lung Innovation
OpenAlex ID: A5053167365
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 · Luca Gianni, Tadeusz Pienkowski, et al. · The Lancet Oncology · 2,427
Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca 2+ release and apoptosis
2008 · Tania Szado, Veerle Vanderheyden, et al. · Proceedings of the National Academy of Sciences · 269
Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
2012 · Javier Cortés, Pierre Fumoleau, et al. · Journal of Clinical Oncology · 252
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
2017 · Giampaolo Bianchini, Astrid Kiermaier, et al. · Breast Cancer Research · 124
PDF
Augmented Contractile Response of Vascular Smooth Muscle in a Diabetic Mouse Model
2003 · Elena B. Okon, Tania Szado, et al. · Journal of Vascular Research · 109
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer
2014 · Y-K Kang, S Y Rha, et al. · British Journal of Cancer · 96
PDF
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2–Altered Advanced Solid Tumors
2023 · Christopher J. Sweeney, John D. Hainsworth, et al. · Journal of Clinical Oncology · 79
PDF
Abstract S3-2: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Antitumor and Safety Analysis of a Randomized Phase II Study ('NeoSphere')
2010 · L Gianni, T Pienkowski, et al. · Cancer Research · 68
Agonist‐induced mitochondrial Ca 2+ transients in smooth muscle
2003 · Tania Szado, Kuo‐Hsing Kuo, et al. · The FASEB Journal · 64
S5-1: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Biomarker Analyses of a 4-Arm Randomized Phase II Study (NeoSphere) in Patients (pts) with HER2−Positive Breast Cancer (BC).
2011 · L Gianni, G Bianchini, et al. · Cancer Research · 49
Sequential opening of IP3-sensitive Ca2+channels and SOC during α-adrenergic activation of rabbit vena cava
2002 · Cheng-Han Lee, Roshanak Rahimian, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 44
Pertuzumab monotherapy following trastuzumab-based treatment: Activity and tolerability in patients with advanced HER2- positive breast cancer
2009 · J. Cortés, J. Baselga, et al. · Journal of Clinical Oncology · 39
Basal calcium entry in vascular smooth muscle
2004 · Damon Poburko, Philippe Lhote, et al. · European Journal of Pharmacology · 33
Pertuzumab and Trastuzumab: Re-Responses to 2 Biological Agents in Patients with HER2-Positive Breast Cancer Which Had Previously Progressed during Therapy with Each Agent Given Separately: A New Biological and Clinical Observation.
2009 · J. Baselga, J. Cortes, et al. · Cancer Research · 21
Pertuzumab, Trastuzumab and Chemotherapy in Her2-Positive Metastatic Gastric or Gastro-Oesophageal Junction Cancer: an International Phase III Study (Jacob)
2013 · Paulo Hoff, Josep Tabernero, et al. · Annals of Oncology · 13
PDF
Endothelin-1-Mediated Wave-Like [Ca2+]i Oscillations in Intact Rabbit Inferior Vena Cava
2007 · Jiazhen Dai, Cheng-Han Lee, et al. · Journal of Vascular Research · 13
Role of sarcoplasmic reticulum in regulation of tonic contraction of rabbit basilar artery
2001 · Tania Szado, Megan McLarnon, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 11
PDF
Clinical Value of Timely Targeted Therapy for Patients With Advanced Non–Small Cell Lung Cancer With Actionable Driver Oncogenes
2024 · Thomas Stricker, Neha Jain, et al. · The Oncologist · 10
PDF
Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab
2025 · Charles Swanton, Russell W. Madison, et al. · Molecular Oncology · 8
PDF
Pertuzumab Pharmacokinetics and Safety in Combination with Trastuzumab and Chemotherapy in Patients with Her2-Positive Advanced Gastric Cancer (Agc)
2013 · Yoon-Koo Kang, Sun Young Rha, et al. · Annals of Oncology · 7
PDF
Emerging therapeutic targets in chronic heart failure: Part II
2003 · Volker Roenicke, Stéphane Leclair, et al. · Expert Opinion on Therapeutic Targets · 7
Abstract CT032: Activity and safety of alectinib for ALK-altered solid tumors from MyPathway
2022 · Charles Swanton, Claire F. Friedman, et al. · Cancer Research · 6
MotHER: A registry for women with breast cancer who received trastuzumab (T) with or without pertuzumab (P) during pregnancy or within 6 months prior to conception.
2013 · Vikki Brown, Ann Partridge, et al. · Journal of Clinical Oncology · 5
Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA
2023 · Lee Schwartzberg, Davey Daniel, et al. · Future Oncology · 4
NGS testing patterns in advanced non-small cell lung cancer (aNSCLC) and metastatic breast cancer (mBC): OneOncology (OO) sites compared to Flatiron Health Nationwide (NAT).
2021 · Ari M. Vanderwalde, Esprit Ma, et al. · Journal of Clinical Oncology · 3
Works count: 52
Citation count: 3,779
H-index: 14
I10-index: 18
Year
Topic
Type